Table 1 .
Inpatient stay (N = 44) | 3-month follow-up (n = 31) | ||||||
---|---|---|---|---|---|---|---|
Measure | Scale range | Mean (SD) | Score range | Mean (SD) | Score range | P-value | η2 |
Resilience (CD-RISC) | 0–40 | 32.36 (5.29) | 17–40 | 30.71 (7.59) | 9–40 | 0.082 | 0.10 |
Depression (PHQ-9) | 0–27 | 4.77 (3.21) | 0–13 | 5.45 (5.46) | 0–25 | 0.949 | <0.01 |
Self-efficacy (SES) | 6–60 | 45.91 (8.18) | 32–60 | 43.71 (13.78) | 18–60 | 0.110 | 0.09 |
Social roles/activity limitations (SRAL) | – | – | – | 7.34 (5.23) | 0–16 | – | – |
Pain | 0–10 | 5.40 (2.38) | 0–10 | 5.52 (1.83) | 1–8 | 0.894 | <0.01 |
CD-RISC, Connor–David Resilience Score; PHQ-9, Patient Health Questionnaire; SES, Self-Efficacy for Managing Chronic Disease Scale; SRAL, Social Role/Activity Limitations Scale. All significant at P < 0.05 entered with covariates as identified in preliminary analysis.